Accelerating Progress in Human Health and Scientific Research

At Parse Biosciences, we are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Single cell RNA sequencing has already enabled breakthroughs in developmental biology, stem cell therapy, immunotherapy, and cancer treatments. Our foundational Evercode™ combinatorial barcoding technology is driving the next generation of discoveries.

Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research.

The People of Parse

The people of Parse are curious, collaborative, and driven by purpose.

Upcoming Events

Alzheimer’s and Brain Awareness Month Webinar Series

Jun 1   -   Jun 28

An estimated 1 billion people worldwide live with a neurological disorder, whether it be Alzheimer's, epilepsy, multiple sclerosis, or cancer, among others. A vibrant community of researchers is committed to further understand these disorders. Throughout the month of June, join us as we shine a light on these researchers and the unique ways they are using Parse Evercode WT single cell RNA sequencing to transform our understanding of the brain.

More Information

Scandinavian Society for Immunology Annual Meeting

Jun 4   -   Jun 7

The SSI2023 meeting brings together immunologists at all career stages, from Ph.D. students to experienced senior scientists interested in various aspects of immunology. The Parse team will be there to talk about our products.

More Information

2023 ESHG

Jun 10   -   Jun 13

Join us for our satellite symposium at ESHG on Monday, June 12, 14:00 – 15:30 BST. Parse staff will be on hand to share information about our single cell platform at booth #134.

More Information